Pages that link to "Q26851291"
Jump to navigation
Jump to search
The following pages link to Cutting through the complexities of mTOR for the treatment of stroke (Q26851291):
Displaying 25 items.
- Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR (Q26749047) (← links)
- Erythropoietin and diabetes mellitus (Q26777878) (← links)
- Stem cell guidance through the mechanistic target of rapamycin (Q26795544) (← links)
- Driving neural regeneration through the mammalian target of rapamycin (Q27027516) (← links)
- Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy (Q28066377) (← links)
- New Insights for Oxidative Stress and Diabetes Mellitus (Q28080679) (← links)
- Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease (Q28085715) (← links)
- WISP1: Clinical insights for a proliferative and restorative member of the CCN family (Q34381111) (← links)
- Regeneration in the nervous system with erythropoietin (Q36247651) (← links)
- Charting a course for erythropoietin in traumatic brain injury. (Q36791150) (← links)
- Autophagy in Diabetic Retinopathy (Q37677015) (← links)
- Programming apoptosis and autophagy with novel approaches for diabetes mellitus (Q38367977) (← links)
- Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders (Q38607849) (← links)
- Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease (Q38789540) (← links)
- The mTOR signalling cascade: paving new roads to cure neurological disease (Q38875632) (← links)
- Inhibition of mTOR signaling Confers Protection against Cerebral Ischemic Injury in Acute Hyperglycemic Rats (Q41377086) (← links)
- mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus (Q42031136) (← links)
- SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer (Q43197576) (← links)
- The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer's Disease, Based on a Mechanistic Target of Rapamycin Pathway. (Q48060988) (← links)
- Sestrin2, as a negative feedback regulator of mTOR, provides neuroprotection by activation AMPK phosphorylation in neonatal hypoxic-ischemic encephalopathy in rat pups. (Q48637827) (← links)
- Rapamycin prevents cerebral stroke by modulating apoptosis and autophagy in penumbra in rats (Q50217592) (← links)
- Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors. (Q51761339) (← links)
- The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders. (Q52361076) (← links)
- FoxO proteins in the nervous system. (Q53622309) (← links)
- Necroptosis Signaling Pathways in Stroke: From Mechanisms to Therapies (Q88383570) (← links)